Home 5 Articles 5 FDA Watch: Agency Resounds the Alarm on Biotin Test Interference

FDA Watch: Agency Resounds the Alarm on Biotin Test Interference

by | Nov 19, 2019

In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning

In early November 2019, the U.S. Food and Drug Administration (FDA) updated a previous safety communication about the potential of biotin to significantly interfere with diagnostic tests. The update reiterates the warning

This content is Exclusive to Diagnostic Testing and Emerging Technologies Subscribers

Subscribe or Log in for Exclusive Access.